uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Mast cell are the predominant CD30L positive cells in Hodgkin's disease, and the CD30L is functionally active
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology.
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology.
Department of Genetics and Pathology. (mast cell biology)
Department of Genetics and Pathology. (mast cell biology)
Show others and affiliations
2001 (English)In: Brit J Haematol, Vol. 114, 616- p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2001. Vol. 114, 616- p.
Identifiers
URN: urn:nbn:se:uu:diva-51646OAI: oai:DiVA.org:uu-51646DiVA: diva2:79555
Available from: 2008-10-17 Created: 2008-10-17 Last updated: 2011-01-14

Open Access in DiVA

No full text

By organisation
Department of Oncology, Radiology and Clinical ImmunologyDepartment of Genetics and PathologyDepartment of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 334 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf